These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1727735)

  • 1. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine.
    Edelstein D; Brownlee M
    Diabetes; 1992 Jan; 41(1):26-9. PubMed ID: 1727735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
    Booth AA; Khalifah RG; Todd P; Hudson BG
    J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.
    Hou FF; Boyce J; Chertow GM; Kay J; Owen WF
    J Am Soc Nephrol; 1998 Feb; 9(2):277-83. PubMed ID: 9527404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
    Lewis BS; Harding JJ
    Exp Eye Res; 1990 May; 50(5):463-7. PubMed ID: 2373149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal.
    Taguchi T; Sugiura M; Hamada Y; Miwa I
    Eur J Pharmacol; 1999 Aug; 378(3):283-9. PubMed ID: 10493104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.
    Kochakian M; Manjula BN; Egan JJ
    Diabetes; 1996 Dec; 45(12):1694-700. PubMed ID: 8922353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine.
    Urios P; Grigorova-Borsos AM; Sternberg M
    Diabetologia; 2004 May; 47(5):959-61. PubMed ID: 15170500
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
    Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
    Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an insulin releasing agent, BTS 67582, on advanced glycation end product formation in vitro.
    Simpson AE; Jones RB
    Life Sci; 1999; 64(16):1427-34. PubMed ID: 10321722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
    Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
    Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking.
    Requena JR; Vidal P; Cabezas-Cerrato J
    Diabetes Res Clin Pract; 1993 Jan; 19(1):23-30. PubMed ID: 8472617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes.
    Chibber R; Molinatti PA; Wong JS; Mirlees D; Kohner EM
    Diabetes; 1994 Jun; 43(6):758-63. PubMed ID: 8194660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation.
    Khatami M; Suldan Z; David I; Li W; Rockey JH
    Life Sci; 1988; 43(21):1725-31. PubMed ID: 3193856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aminoguanidine and copper(II) ions on the formation of advanced glycosylation end products. In vitro study on human serum albumin.
    Jakus V; Bauerová K; Rietbrock N
    Arzneimittelforschung; 2001; 51(4):280-3. PubMed ID: 11367867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro advanced glycation end product formation in rat tail tendon fibers: influence of aminoguanidine.
    Troncoso IA; Esteban MM; Ruiz MA; Flórez L; Barneo L
    Transplant Proc; 1995 Dec; 27(6):3345-6. PubMed ID: 8539985
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine.
    Duraisamy Y; Gaffney J; Slevin M; Smith CA; Williamson K; Ahmed N
    Mol Cell Biochem; 2003 Apr; 246(1-2):143-53. PubMed ID: 12841356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose.
    Watkins NG; Thorpe SR; Baynes JW
    J Biol Chem; 1985 Sep; 260(19):10629-36. PubMed ID: 4030761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.